Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Toxicology ; 337: 47-57, 2015 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-26318284

RESUMEN

The ubiquitin-proteasome system (UPS) is a specific, non-lysosomal pathway responsible for the controlled degradation of abnormal and short-half-life proteins. Despite its relevance in cell homeostasis, information regarding control of the UPS component gene expression is lacking. Data from a recent study suggest that the aryl hydrocarbon receptor (AHR), a ligand-dependent transcription factor, might control the expression of several genes encoding for UPS proteins. Here, we showed that activation of AHR by TCDD and ß-naphthoflavone (ß-NF) results in Ubcm4 gene induction accompanied by an increase in protein levels. UbcM4 is an ubiquitin-conjugating enzyme or E2 protein that in association with ubiquitin ligase enzymes or E3 ligases promotes the ubiquitination and 26S proteasome-mediated degradation of different proteins, including p53, c-Myc, and c-Fos. We also present data demonstrating increased c-Fos ubiquitination and proteasomal degradation through the AHR-mediated induction of UbcM4 expression. The present study shows that AHR modulates the degradation of proteins involved in cell cycle control, consistent with previous reports demonstrating an essential role of the AHR in cell cycle regulation.


Asunto(s)
Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Proteínas Proto-Oncogénicas c-fos/metabolismo , Receptores de Hidrocarburo de Aril/efectos de los fármacos , Enzimas Ubiquitina-Conjugadoras/biosíntesis , Ubiquitinación/efectos de los fármacos , Línea Celular , Expresión Génica/efectos de los fármacos , Técnicas de Silenciamiento del Gen , Humanos , Plásmidos/efectos de los fármacos , Dibenzodioxinas Policloradas/farmacología , Proteínas Proto-Oncogénicas c-fos/efectos de los fármacos , Transfección , Enzimas Ubiquitina-Conjugadoras/efectos de los fármacos , Enzimas Ubiquitina-Conjugadoras/genética , beta-naftoflavona/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA